{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:49:23Z","timestamp":1792788563689,"version":"4.5.0"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondecyt","award":["1200964"],"award-info":[{"award-number":["1200964"]}]},{"name":"pfizer chile"},{"name":"bioM\u00c3\u00a9rieux chile"},{"name":"gador"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Invasive mold diseases (IMDs) are a severe complication of immunocompromised subjects and an emerging problem among severely ill, apparently immunocompetent patients. The aim of this study was to describe the epidemiological and clinical features of IMDs in Chile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective study of IMD cases in children and adults from 11 reference hospitals in Chile from May 2019 to May 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      One hundred seventy-six cases were included, 135 in adults and 41 in children, with an overall incidence of 0.4\/1,000 admissions. The median age was 10.5 years in children and 56.6 years in adults, with male gender predominance in adults (61.5% versus 41.5%, p\u2009=\u20090.03). Immunosuppression was the most common condition in both children and adults. However, cancer, neutropenia, and hematopoietic cell transplantation were significantly more frequent in the pediatric group. In contrast, diabetes, viral pneumonia, chronic kidney disease, and chronic obstructive pulmonary disease were significantly more frequent among adult patients. Regarding the diagnostic category, 30.1% of cases were proven, 55.7% probable and 14.2% possible. Aspergillosis was the most frequent IMD diagnosed in 75.5% of cases, followed by fusariosis in children and mucormycosis in adults. Viral pneumonia was associated in 40.3% of cases, mainly COVID-19, with aspergillosis in 87.3%. No triazole resistance was observed in\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      spp.. Antifungals were prescribed in 97.2% of the patients: voriconazole 61.4%, liposomal amphotericin 20.5%, combination antifungals 11.1%, and others 6.4%. Overall survival was 68.7%, 61.4%, and 51.7% at 30, 90 and 180 days, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      This is the most extensive study of IMDs in Chile, evidencing an incidence of 0.4 per 1,000 admissions, with aspergillosis being the most frequent infection. Nearly 40% of cases were associated with respiratory viruses, accounting for the impact of COVID-19. Despite almost all patients starting antifungal therapy, the survival rate was poor. It is advisable to start a surveillance program of IMDs in Chile and verify the absence of azole resistance of\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      spp.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0330426","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T17:44:23Z","timestamp":1757353463000},"page":"e0330426","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["A prospective, multicenter study of invasive fungal disease caused by molds in children and adults in Chile"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0574-8312","authenticated-orcid":true,"given":"Ricardo","family":"Rabagliati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dona","family":"Benadof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Vizcaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yenis","family":"Labra\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Zubieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Contardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yocelyn","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Ducasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1796-2236","authenticated-orcid":true,"given":"Mario","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Santolaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Chilean Invasive Mycosis Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"issue":"165","key":"pone.0330426.ref001","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"GD Brown","year":"2012","journal-title":"Sci Transl Med"},{"issue":"8","key":"pone.0330426.ref002","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/1469-0691.12014","article-title":"Hema e-Chart registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections","volume":"19","author":"AM Nosari","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"pone.0330426.ref003","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry","volume":"48","author":"D Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"key":"pone.0330426.ref004","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/jof7100848","article-title":"Changing epidemiology of invasive fungal disease in allogeneic hematopoietic stem cell transplantation","volume":"7","author":"P Puerta-Alcalde","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"3","key":"pone.0330426.ref005","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.idc.2018.04.006","article-title":"Mold infections in solid organ transplant recipients","volume":"32","author":"TL Lemonovich","year":"2018","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"pone.0330426.ref006","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/jpids\/pix041","article-title":"Invasive fungal disease in pediatric solid organ transplant recipients","volume":"7","author":"S Saxena","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"pone.0330426.ref007","article-title":"Clinical risk factors for invasive aspergillosis","author":"JW Baddley","year":"2011","journal-title":"Med Mycol"},{"issue":"6","key":"pone.0330426.ref008","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1055\/s-0040-1702210","article-title":"Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease exacerbations","volume":"41","author":"P Bulpa","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"pone.0330426.ref009","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s40121-021-00524-5","article-title":"Invasive pulmonary aspergillosis in acute-on-chronic liver failure patients: short-term outcomes and antifungal options","volume":"10","author":"D Chen","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"6","key":"pone.0330426.ref010","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s11739-021-02705-z","article-title":"Putative invasive pulmonary aspergillosis within medical wards and intensive care units: a 4-year retrospective, observational, single-centre study","volume":"16","author":"S Corcione","year":"2021","journal-title":"Intern Emerg Med"},{"key":"pone.0330426.ref011","doi-asserted-by":"crossref","first-page":"101037","DOI":"10.1016\/j.mycmed.2020.101037","article-title":"Aspergillus peritonitis in peritoneal dialysis patients: a systematic review","volume":"30","author":"J Dotis","year":"2020","journal-title":"J Mycol Med"},{"issue":"5","key":"pone.0330426.ref012","first-page":"463","article-title":"Invasive pulmonary aspergillosis in the ICU: tale of a broadening risk profile","volume":"29","author":"D Koulenti","year":"2023","journal-title":"Curr Opin Crit Care"},{"issue":"4","key":"pone.0330426.ref013","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1164\/rccm.201612-2540LE","article-title":"Influenza-associated Aspergillosis in critically ill patients","volume":"196","author":"FL van de Veerdonk","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"pone.0330426.ref014","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.chest.2023.09.019","article-title":"Prevalence, risk factors, clinical features, and outcome of influenza-associated pulmonary Aspergillosis in critically ill patients: a systematic review and meta-analysis","volume":"165","author":"LY Lu","year":"2024","journal-title":"Chest"},{"key":"pone.0330426.ref015","doi-asserted-by":"crossref","first-page":"102365","DOI":"10.1016\/j.mib.2023.102365","article-title":"Fungal pathogens and COVID-19","volume":"75","author":"A Singh","year":"2023","journal-title":"Curr Opin Microbiol"},{"issue":"6","key":"pone.0330426.ref016","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3390\/jof9060689","article-title":"Mortality in ICU patients with COVID-19-associated pulmonary Aspergillosis","volume":"9","author":"A Beltrame","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"pone.0330426.ref017","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3390\/jof7070556","article-title":"Epidemiology of systemic mycoses in the COVID-19 pandemic","volume":"7","author":"MG Fr\u00edas-De-Le\u00f3n","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"10","key":"pone.0330426.ref018","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/myc.13339","article-title":"Serious fungal diseases in Democratic Republic of Congo - incidence and prevalence estimates","volume":"64","author":"GK Kamwiziku","year":"2021","journal-title":"Mycoses"},{"issue":"3","key":"pone.0330426.ref019","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/myc.12427","article-title":"The burden of serious human fungal infections in Brazil","volume":"59","author":"J Giacomazzi","year":"2016","journal-title":"Mycoses"},{"issue":"6","key":"pone.0330426.ref020","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s10096-017-2922-y","article-title":"Serious fungal infections in Canada","volume":"36","author":"SF Dufresne","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"pone.0330426.ref021","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.3201\/eid2609.200016","article-title":"Risk-based estimate of human fungal disease burden, China","volume":"26","author":"L-H Zhou","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"pone.0330426.ref022","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.mycmed.2016.11.001","article-title":"An estimation of burden of serious fungal infections in France","volume":"26","author":"JP Gangneux","year":"2016","journal-title":"J Mycol Med"},{"issue":"6","key":"pone.0330426.ref023","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s10096-017-2925-8","article-title":"Serious fungal infections in Chile","volume":"36","author":"E Alvarez Duarte","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"pone.0330426.ref024","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/INF.0b013e3181e7db7f","article-title":"Risk factors associated with invasive fungal disease in children with cancer and febrile neutropenia: a prospective multicenter evaluation","volume":"29","author":"M Villarroel","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"pone.0330426.ref025","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4067\/S0716-10182014000600013","article-title":"Epidemiology of febrile neutropenia in adult patients with acute leukemia and lymphoma: cohort study of public and private hospital of Santiago, Chile","volume":"31","author":"R Rabagliati","year":"2014","journal-title":"Rev Chilena Infectol"},{"issue":"3","key":"pone.0330426.ref026","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12281-021-00418-6","article-title":"Emergence of triazole resistance in Aspergillus spp. in Latin America","volume":"15","author":"D Macedo","year":"2021","journal-title":"Curr Fungal Infect Rep"},{"issue":"7","key":"pone.0330426.ref027","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/jac\/dkz121","article-title":"Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico","volume":"74","author":"MF Gonzalez-Lara","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"pone.0330426.ref028","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/mmy\/myz032","article-title":"Azole resistance among clinical isolates of Aspergillus fumigatus in Lima-Peru","volume":"58","author":"B Bustamante","year":"2020","journal-title":"Med Mycol"},{"key":"pone.0330426.ref029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212924","article-title":"A prospective, multicenter study of Candida bloodstream infections in Chile","volume":"14","author":"ME Santolaya","year":"2019","journal-title":"PLoS One"},{"key":"pone.0330426.ref030","volume-title":"Epidemiological Cut-off Values for Antifungal Susceptibility Testing","author":"Clinical and Laboratory Standard Institute (CLSI)","year":"2022","edition":"4"},{"issue":"1","key":"pone.0330426.ref031","article-title":"Fungal nomenclature: managing change is the name of the game","volume":"10","author":"SE Kidd","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"pone.0330426.ref032","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.00873-23","article-title":"A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI, ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC","volume":"61","author":"S de Hoog","year":"2023","journal-title":"J Clin Microbiol"},{"issue":"6","key":"pone.0330426.ref033","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"JP Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"pone.0330426.ref034","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"P Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"pone.0330426.ref035","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/myc.12960","article-title":"Mycoses Study Group Education and Research Consortium (MSG-ERC) and the European Confederation of Medical Mycology (ECMM). Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology","volume":"62","author":"OA Cornely","year":"2019","journal-title":"Mycoses"},{"issue":"5","key":"pone.0330426.ref036","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria","volume":"47","author":"BH Segal","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pone.0330426.ref037","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00920-22","article-title":"Active surveillance program to increase awareness on invasive fungal diseases: the French RESSIF Network (2012 to 2018)","volume":"13","author":"S Bretagne","year":"2022","journal-title":"mBio"},{"key":"pone.0330426.ref038","doi-asserted-by":"crossref","DOI":"10.1111\/j.1439-0507.2011.02032.x","article-title":"Emerging moulds: epidemiological trends and antifungal resistance","volume":"54","author":"MH Miceli","year":"2011","journal-title":"Mycoses"},{"issue":"3","key":"pone.0330426.ref039","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/mmy\/myx055","article-title":"Erratum: epidemiology and clinical characteristics of invasive mould infections: a multicenter, retrospective analysis in five Asian countries","volume":"56","author":"P Rotjanapan","year":"2018","journal-title":"Med Mycol"},{"issue":"2","key":"pone.0330426.ref040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/jof4020051","article-title":"Burden of serious fungal infections in Argentina","volume":"4","author":"FO Riera","year":"2018","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"pone.0330426.ref041","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1590\/0037-8682-0191-2016","article-title":"Invasive fungal infection in patients with hematologic disorders in a Brazilian tertiary care hospital","volume":"50","author":"MJ Camplesi","year":"2017","journal-title":"Rev Soc Bras Med Trop"},{"issue":"8","key":"pone.0330426.ref042","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/jof7080588","article-title":"Epidemiology of invasive fungal diseases in patients with hematologic malignancies and hematopoietic cell transplantation recipients managed with an antifungal diagnostic driven approach","volume":"7","author":"MD Bergamasco","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"pone.0330426.ref043","article-title":"Invasive mould infections in newborns and children","author":"E Castagnola","year":"2011","journal-title":"Early Hum Dev"},{"issue":"6","key":"pone.0330426.ref044","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/QCO.0000000000000776","article-title":"How different is invasive fusariosis in pediatric patients than in adults? A systematic review","volume":"34","author":"L Rossato","year":"2021","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"pone.0330426.ref045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/jof5010026","article-title":"Global epidemiology of mucormycosis","volume":"5","author":"H Prakash","year":"2019","journal-title":"J Fungi (Basel)"},{"issue":"5","key":"pone.0330426.ref046","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey","volume":"43","author":"A Cornillet","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"7","key":"pone.0330426.ref047","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","article-title":"Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome","volume":"16","author":"J Guinea","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"pone.0330426.ref048","doi-asserted-by":"crossref","first-page":"631461","DOI":"10.3389\/fmed.2021.631461","article-title":"The clinical characteristics of patients with nonneutropenic invasive pulmonary Aspergillosis","volume":"8","author":"L Liu","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"pone.0330426.ref049","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cid\/ciu833","article-title":"Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial","volume":"60","author":"JM Aguado","year":"2015","journal-title":"Clin Infect Dis"},{"key":"pone.0330426.ref050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jinf.2023.05.005","article-title":"Breakthrough invasive fungal infection among patients with haematologic malignancies: a national, prospective, and multicentre study","volume":"87","author":"P Puerta-Alcalde","year":"2023","journal-title":"J Infect"},{"key":"pone.0330426.ref051","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/cid\/ciy473","article-title":"Breakthrough invasive mold infections in the hematology patient: current concepts and future directions","volume":"67","author":"MS Lionakis","year":"2018","journal-title":"Clin Infect Dis"},{"key":"pone.0330426.ref052","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","author":"AJ Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"pone.0330426.ref053","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"OA Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"pone.0330426.ref054","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1469-0691.12465","article-title":"ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others","volume":"3","author":"AM Tortorano","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"pone.0330426.ref055","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/mmy\/myz006","article-title":"Impact of dose adaptations following voriconazole therapeutic drug monitoring in pediatric patients","volume":"57","author":"VJ Lempers","year":"2019","journal-title":"Med Mycol"},{"key":"pone.0330426.ref056","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01093-21","article-title":"Etest ECVs\/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent Candida spp. to Triazoles and Amphotericin B and Aspergillus spp. to Caspofungin: Further Assessment of Modal Variability","volume":"65","author":"A Espinel-Ingroff","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0330426.ref057","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/jof5030055","article-title":"Invasive Aspergillosis by Aspergillus flavus: Epidemiology, Diagnosis, Antifungal Resistance, and Management","volume":"5","author":"SM Rudramurthy","year":"2019","journal-title":"J Fungi (Basel)"},{"issue":"2","key":"pone.0330426.ref058","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/JCM.02136-10","article-title":"Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Aspergillus species to the triazoles","volume":"49","author":"M Pfaller","year":"2011","journal-title":"J Clin Microbiol"},{"key":"pone.0330426.ref059","article-title":"Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin","author":"RE Gardiner","year":"2005","journal-title":"Med Mycol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0330426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T17:44:49Z","timestamp":1757353489000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0330426"}},"subtitle":[],"editor":[{"given":"Nosheen","family":"Nasir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":59,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0330426","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]}}}